Showing results (391-400 of 403) with videos related to
Sort By:
Pageof 41
Brain : a Journal of Neurology|March 28, 2023
Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trialsDuncan Street, Edwin Jabbari, Alyssa Costantini, et al.Nature|May 20, 2021
MIR-NATs repress MAPT translation and aid proteostasis in neurodegenerationRoberto Simone, Faiza Javad, Warren Emmett, et al.The Lancet. Public Health|August 4, 2020
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort studyLong H Nguyen, David A Drew, Mark S Graham, et al.Diabetic Medicine : a Journal of the British Diabetic Association|December 17, 2014
Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparisonJ A McKnight, S H Wild, M J E Lamb, et al.The Lancet. Neurology|June 20, 2025
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort studyChristina D Orrú, David P Vaughan, Nirosen Vijiaratnam, et al.JAMA Neurology|December 21, 2019
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal SyndromeEdwin Jabbari, Negin Holland, Viorica Chelban, et al.The Lancet. Neurology|March 28, 2016
Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association dataKin Y Mok, Una Sheerin, Javier Simón-Sánchez, et al.JAMA Neurology|June 8, 2026
Pathology and Genetics in a Global Cohort of Parkinsonian DisordersLesley Y Wu, Tessa du Toit, Tatiana Georgiades, et al.Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Pathology and genetics in a global cohort of Parkinsonian DisordersLesley Y Wu, Tessa du Toit, Tatiana Georgiades, et al.Nature Communications|September 9, 2024
Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genesKurt Farrell, Jack Humphrey, Timothy Chang, et al.Pageof 41